IP Verse

Merck Serono patent opposition analysis

The comprehensive analysis of Merck Serono opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Merck Serono

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP3021869	Methods Of Treating Cancer Using Pd-1 Axis Binding Antagonists And Tigit Inhibitors	F HOFFMANN LA ROCHE	Apr 15, 2021	ARES TRADING
EP3303632	Therapeutic And Diagnostic Methods For Cancer	F HOFFMANN LA ROCHE	Dec 4, 2020	ARES TRADING
EP3083686	Methods Of Treating Cancers Using Pd-1 Axis Binding Antagonists And Taxanes	F HOFFMANN LA ROCHE	Jul 23, 2020	ARES TRADING

Top companies who are the clients of Merck Serono

Company	Total
ARES TRADING	3